← back to search

Sunish Mohanan

Gilead Sciences (United States) · US
Area of research
Genetics · Oncology
Research interest
Research interests include Virus-based gene therapy research, CAR-T cell therapy research, Cancer Research and Treatments, and Glioma Diagnosis and Treatment.
h-index
17
citations
1,678
works
66
NIH funding
primary concept
email

Recent publications

Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS)
Biomaterials 2019cited by 34position: middledoi
Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis
Science Translational Medicine 2015cited by 360position: middledoi
Glioblastoma Stem Cells Are Regulated by Interleukin-8 Signaling in a Tumoral Perivascular Niche
Cancer Research 2013cited by 181position: middledoi
Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelial-to-mesenchymal transition in breast cancer cells
Proceedings of the National Academy of Sciences 2013cited by 129position: middledoi
Identification of Macrophage Extracellular Trap-Like Structures in Mammary Gland Adipose Tissue: A Preliminary Study
Frontiers in Immunology 2013cited by 120position: firstdoi
In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model
Journal of Bone and Mineral Research 2013cited by 104position: middledoi
Implanted adipose progenitor cells as physicochemical regulators of breast cancer
Proceedings of the National Academy of Sciences 2012cited by 148position: middledoi
Potential Role of Peptidylarginine Deiminase Enzymes and Protein Citrullination in Cancer Pathogenesis
Biochemistry Research International 2012cited by 128position: firstdoi
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
BMC Cancer 2012cited by 120position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Claudia Fischbach · Cornell University5 papers (2012–2019)Scott A. Coonrod · Cornell University4 papers (2012–2013)John L. McElwee · Eli Lilly (United States)3 papers (2012–2013)Brian D. Cherrington · Nanjing Medical University3 papers (2012–2013)Clifford A. Hudis · American Society of Clinical Oncology2 papers (2015–2019)Patrick G. Morris · Hospital Universitario Virgen del Rocío2 papers (2015–2019)Bo Ri Seo · Harvard University2 papers (2012–2015)Sachi Horibata · Michigan Department of Health and Human Services2 papers (2012–2013)Delphine Gourdon · Centre for Advanced Study2 papers (2012–2015)Rebecca M. Williams · Cornell University2 papers (2012–2015)Andrew J. Dannenberg · BioVentures (United States)2 papers (2013–2015)Roberto C. Andresen Eguiluz · University of California, Merced2 papers (2012–2015)Jacqueline González · El Hospital General de Agudos Carlos G. Durand1 papers (2015–2015)Brina S. Lopez · Midwestern University1 papers (2013–2013)John A. Boockvar · Northwell Health1 papers (2013–2013)C. Theresa Vincent · Karolinska Institutet1 papers (2013–2013)David W. Infanger · Koronis Biomedical Technologies (United States)1 papers (2013–2013)Matthew A. Whitman · Cornell University1 papers (2019–2019)Emily M. Chandler · Cornell University1 papers (2012–2012)Ashley M. Palmer · University of Oxford1 papers (2012–2012)